Bedel Financial Consulting, Inc. - PERNIX THERAPEUTICS HLDGS IN ownership

PERNIX THERAPEUTICS HLDGS IN's ticker is PTXTQ and the CUSIP is 71426V306. A total of 2 filers reported holding PERNIX THERAPEUTICS HLDGS IN in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Bedel Financial Consulting, Inc. ownership history of PERNIX THERAPEUTICS HLDGS IN
ValueSharesWeighting
Q4 2018$070.0%0.00%
Q3 2018$070.0%0.00%
Q2 2018$070.0%0.00%
Q1 2018$070.00%
Other shareholders
PERNIX THERAPEUTICS HLDGS IN shareholders Q1 2019
NameSharesValueWeighting ↓
Aisling Capital LLC 210,000$510,0000.07%
Cetera Investment Advisers 46,750$113,0000.02%
SEARLE & CO. 13,325$32,0000.02%
JACOBS LEVY EQUITY MANAGEMENT, INC 87,643$213,0000.00%
Renaissance Technologies 1,895,000$4,568,0000.00%
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO 7$00.00%
IFP Advisors, Inc 250$1,0000.00%
Advisor Group, Inc. 177$00.00%
SEI INVESTMENTS CO 5$00.00%
BANK OF AMERICA CORP /DE/ 11$00.00%
View complete list of PERNIX THERAPEUTICS HLDGS IN shareholders